These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8531590)

  • 21. Rheumatoid Factors in Hepatitis B and C Infections: Connecting Viruses, Autoimmunity, and Cancer.
    Moll J; Isailovic N; De Santis M; Selmi C
    Isr Med Assoc J; 2019 Jul; 21(7):480-486. PubMed ID: 31507125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 autoimmune hepatitis and hepatitis C virus infection.
    Lenzi M; Ballardini G; Fusconi M; Cassani F; Selleri L; Volta U; Zauli D; Bianchi FB
    Lancet; 1990 Feb; 335(8684):258-9. PubMed ID: 1967721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB; Taswell HF; Homburger HA
    J Hepatol; 1993 Jul; 18(3):342-52. PubMed ID: 8228128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune hepatitis type 2 and hepatitis C virus infection: study of HLA antigens.
    Jurado A; Cárdaba B; Jara P; Cuadrado P; Hierro L; de Andrés B; del Pozo V; Cortegano MI; Gallardo S; Camarena C; Bárcena R; Castañer JL; Alvarez R; Lahoz C; Palomino P
    J Hepatol; 1997 May; 26(5):983-91. PubMed ID: 9186828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
    Heintges T; Niederau C
    Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LKM3 autoantibodies in hepatitis C cirrhosis: a further phenomenon of the HCV-induced autoimmunity.
    Csepregi A; Nemesánszky E; Luettig B; Obermayer-Straub P; Manns MP
    Am J Gastroenterol; 2001 Mar; 96(3):910-1. PubMed ID: 11280576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune hepatitis in children and hepatitis C virus testing.
    Dussaix E; Maggiore G; De Giacomo C; Mondelli M; Martres P; Alvarez F
    Lancet; 1990 May; 335(8698):1160-1. PubMed ID: 1971892
    [No Abstract]   [Full Text] [Related]  

  • 30. Hepatitis C virus antibody in patients with chronic autoimmune hepatitis: pitfalls in diagnosis and implications for treatment.
    Davis GL
    Mayo Clin Proc; 1991 Jun; 66(6):647-50. PubMed ID: 1646354
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China.
    Yang R; Shan Z; Li Y; Fan C; Li C; Teng W
    Intern Med; 2011; 50(8):811-5. PubMed ID: 21498927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis.
    Treichel U; Gerken G; Rossol S; Rotthauwe HW; Meyer zum Büschenfelde KH; Poralla T
    J Hepatol; 1993 Aug; 19(1):55-63. PubMed ID: 8301043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic hepatitis C and Gougerot-Sjogren syndrome. Apropos of a case].
    Poët JL; Garnier PP; Tonolli-Serabian I; Mattei JP; Gauthier A; Roux H
    Rev Rhum Ed Fr; 1993 Apr; 60(4):305-7. PubMed ID: 8167629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C infection and autoimmunity.
    Eddleston AL
    J Hepatol; 1996; 24(2 Suppl):55-60. PubMed ID: 8836890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune hepatitis: the lesson of the discovery of hepatitis C virus.
    Bianchi FB
    J Hepatol; 1993 Jul; 18(3):273-5. PubMed ID: 8228118
    [No Abstract]   [Full Text] [Related]  

  • 37. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C.
    García-Buey L; García-Monzón C; Rodriguez S; Borque MJ; García-Sánchez A; Iglesias R; DeCastro M; Mateos FG; Vicario JL; Balas A
    Gastroenterology; 1995 Jun; 108(6):1770-7. PubMed ID: 7768382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C.
    Clifford BD; Donahue D; Smith L; Cable E; Luttig B; Manns M; Bonkovsky HL
    Hepatology; 1995 Mar; 21(3):613-9. PubMed ID: 7533120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-HCV, anti-GOR, and autoimmunity.
    Magrin S; Pinzello G; Craxì A; Almasio P; Pagliaro L
    Lancet; 1992 Apr; 339(8797):871. PubMed ID: 1347879
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience.
    Bianchi FB; Cassani F; Lenzi M; Ballardini G; Muratori L; Giostra F; Zauli D
    Dig Dis Sci; 1996 Jan; 41(1):166-71. PubMed ID: 8565751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.